Human cryosleep, in any form resembling the pods of science fiction, remains decades away at a minimum. No one has reversibly placed a human being into a state of deep metabolic suspension and brought them back, and every component technology needed to do so is still in an early experimental phase. That said, research has accelerated on several fronts: scientists have triggered torpor-like states in mice that do not naturally hibernate, transplanted organs that were frozen to glass and rewarmed using nanoparticles, and begun the first clinical trial of deep cooling for trauma patients in cardiac arrest. The gap between where the science stands today and what a working cryosleep system would demand is vast, but it is no longer entirely speculative.
What Cryosleep Would Actually Require
The word “cryosleep” blurs two very different ideas. One is torpor: dramatically slowing metabolism so the body needs almost no oxygen, food, or water for an extended period, then waking up intact. The other is cryopreservation: cooling tissue to temperatures so low that all biological activity stops, storing it indefinitely, and then rewarming it without damage. A practical cryosleep system would likely need elements of both. Metabolism would need to drop far enough that cells stop aging and accumulating damage, and the cooling and rewarming process would need to leave every organ, tissue, and neural connection functionally intact. Each of those requirements is, on its own, an unsolved problem.
Inducing Torpor in Animals That Don’t Hibernate
Humans do not hibernate, and for a long time the assumption was that non-hibernating mammals simply lacked the neural wiring to enter torpor. That assumption has been challenged. Researchers found that activating a specific set of neurons in the mouse brain’s preoptic area, neurons that express estrogen receptor alpha, could trigger a rapid drop in core body temperature below 30 °C within an hour, along with a broad suppression of metabolic rate. The mice entered a state that looked a lot like natural torpor, and they recovered without apparent harm once the stimulus was removed.1Nature Communications. Estrogen-sensitive medial preoptic area neurons coordinate torpor in mice This was a major conceptual breakthrough: it showed that a torpor-like switch might exist even in species that never use it in the wild.
Pharmacological approaches have also been explored. In 2005, a landmark experiment demonstrated that exposing mice to hydrogen sulfide gas could induce a suspended-animation-like state. The mice’s metabolic rate plummeted, their core temperature dropped toward ambient levels, and the effect was reversible without obvious injury.2PubMed. H2S induces a suspended animation-like state in mice Hydrogen sulfide works by depressing mitochondrial function, essentially throttling the cellular machinery that burns oxygen for energy.3PubMed Central. Is hydrogen sulfide-induced suspended animation general anesthesia? The catch is that this effect has proven difficult to reproduce in larger animals. Mice are tiny, with a high surface-area-to-volume ratio, so their body temperature naturally drops fast when metabolism slows. A 70-kilogram human body retains heat much more stubbornly, and hydrogen sulfide at the concentrations needed becomes dangerously toxic in larger mammals. The search for a pharmacological torpor trigger that works across body sizes is ongoing, but no candidate has scaled up successfully.
Lessons from Animals That Do Hibernate
Natural hibernators are a goldmine of biological insight, because they solve problems that would kill a human under the same conditions. When a thirteen-lined ground squirrel enters torpor, its heart rate falls to three to five beats per minute and its body temperature hovers around 4 to 8 °C for weeks at a time. A human at those temperatures would develop fatal blood clots from the stagnant blood flow, but the ground squirrel does not. Its body reversibly suppresses blood clotting by pulling platelets out of circulation and reducing coagulation factors during torpor, then rapidly restoring them upon arousal.4PubMed Central. Hibernation and hemostasis Even more remarkable, ground squirrel platelets survive prolonged cold storage and return to full function once the animal warms up. Platelets from non-hibernating mammals, including humans, suffer cold-induced damage that causes them to be rapidly cleared from the bloodstream after rewarming.5PubMed Central. The hibernating 13-lined ground squirrel as a model organism for potential cold storage of platelets
The immune system is another complication. During torpor, circulating white blood cells of all types drop dramatically, and functions like pathogen recognition, antibody production, and inflammatory signaling are all suppressed.6PubMed. Hibernation: the immune system at rest? For a hibernating ground squirrel in a sealed burrow, the infection risk is manageable. For a human in a clinical setting, months of near-total immune suppression would be a serious vulnerability. The devastating spread of white-nose syndrome among hibernating bats is a cautionary example of what happens when a pathogen encounters an animal whose immune defenses are offline.
Cell membranes also undergo changes during hibernation. Lipid composition shifts to maintain membrane fluidity at low temperatures, a process involving changes in fatty acid saturation, cholesterol ratios, and phospholipid profiles.7PubMed. Lipids in mammalian hibernation and artificial hypobiosis Cold-adapted organisms increase their proportion of unsaturated fatty acids in membranes, which prevents the membranes from becoming rigid and brittle when temperatures fall.8PubMed Central. Molecular Mechanisms of Lipid-Based Metabolic Adaptation Strategies in Response to Cold Human cell membranes are not optimized for this. Any practical human torpor system would need to either pretreat the body to modify membrane composition or find a pharmacological way to maintain membrane integrity at low temperatures.
There is also the question of what prolonged torpor does to the brain. Research on natural hibernators shows that neural connections are extensively remodeled during torpor, with synapses pruned and rebuilt during each arousal cycle. How this affects cognition in hibernating animals is still being worked out, and the precise mechanisms governing the torpor-arousal transition and their influence on neural function remain poorly understood.9PubMed Central. Human torpor: translating insights from nature into manned deep space expedition For human cryosleep, preserving memory and personality across a torpor period is a non-negotiable requirement that has barely been studied.
Emergency Preservation and Resuscitation
The closest thing to human cryosleep currently being tested in a clinical setting is Emergency Preservation and Resuscitation, or EPR, a procedure designed for trauma patients in cardiac arrest who would otherwise die on the operating table. EPR works by rapidly flushing ice-cold saline into the patient’s aorta, cooling the body to about 10 °C at the eardrum. At that temperature, cells consume so little oxygen that surgeons can have up to two hours of circulatory arrest to repair injuries before attempting resuscitation.10PubMed. Emergency preservation and resuscitation for cardiac arrest from trauma The approach was developed and validated in large-animal experiments, where animals were exsanguinated to the point of cardiac arrest, cooled, held at 10 °C while injuries were repaired, and then revived with normal neurological recovery.11PubMed. Development of the emergency preservation and resuscitation for cardiac arrest from trauma clinical trial
EPR is extraordinary for what it is, but it illustrates how far we are from cryosleep. The suspension lasts at most a couple of hours, not days or months. The body temperature drops to 10 °C, not the sub-zero range needed for long-term preservation. And the procedure is designed as a last-ditch effort to save someone who is already dying. Still, it is genuine proof of concept that a human body can be profoundly cooled, held in a near-death state, and brought back. Every cryosleep scenario builds on the biology that makes EPR possible.
The Ice Crystal Problem
Cooling a human body below freezing, as science fiction often imagines, runs headlong into the most fundamental obstacle in cryobiology: ice. When water inside cells freezes, the expanding crystals shred membranes and organelles. Even extracellular ice draws water out of cells by osmosis, causing them to shrivel and die. The damage is not subtle; frostbite research has shown that freezing and thawing tissue triggers a cascade of injury including direct cell rupture, blood vessel damage, and a reperfusion injury similar to what happens when blood flow is restored after a heart attack. Free radicals generated during rewarming contribute to tissue death on top of the mechanical damage from ice itself.12PubMed. Evidence for an early free radical-mediated reperfusion injury in frostbite Cryopreservation at any scale involves multiple overlapping injury pathways, including apoptosis, necrosis, and ischemia-reperfusion injury.13PubMed Central. Biomolecular Pathways of Cryoinjuries in Low-Temperature Storage for Mammalian Specimens
The solution researchers have pursued is vitrification: replacing enough of the water in tissue with cryoprotectant chemicals that the fluid transitions to a glass-like amorphous solid rather than forming crystals. This avoids ice entirely, and advances in understanding the physics of heat and mass transfer during vitrification have improved the process considerably over the past decade.14PubMed Central. Technologies for Vitrification Based Cryopreservation Vitrification works well for small samples: embryos, oocytes, and thin tissue slices are routinely vitrified and recovered in fertility clinics worldwide. Scaling it to whole organs, let alone entire bodies, is where everything gets harder.
Cryoprotectant Toxicity
The chemicals that prevent ice formation are themselves harmful. Common cryoprotective agents like DMSO, glycerol, and propylene glycol are effective at reducing intracellular ice, but their usefulness is limited by the fact that they are toxic to cells at the concentrations needed for vitrification.15Current Nanomedicine. Cryoprotectants and Lyoprotectants: A Complete Assessment of Mechanism, Toxicity, and Applications for Pharmaceuticals The problem is a fundamental trade-off: you need enough cryoprotectant to prevent ice, but the more you use, the more damage you do to the cells you are trying to protect.
Researchers have made progress in understanding why some cryoprotectant mixtures are less toxic than others. One leading framework measures how strongly a cryoprotectant’s chemical groups interact with water molecules at the minimum concentration needed to vitrify. Mixtures where fewer water molecules are tied up per unit of cryoprotectant tend to be less toxic, because more water remains available to keep proteins and other cellular structures properly hydrated.16PubMed Central. Cryoprotectant Toxicity: Facts, Issues, and Questions This insight has guided the development of newer cryoprotectant cocktails, but no combination yet exists that can vitrify a large organ without causing significant cell damage during the loading and unloading phases.
Rewarming and the Nanowarming Breakthrough
Even if you could vitrify a large organ perfectly, bringing it back is its own problem. During rewarming, if any part of the tissue warms too slowly, the glassy cryoprotectant can devitrify, meaning it crystallizes into ice. Warm too unevenly, and thermal stress can crack the organ like a frozen windshield. For small samples, fast uniform rewarming in a warm bath works fine. For something the size of a kidney or a heart, the outside warms faster than the inside, creating exactly the kind of temperature gradients that cause cracking and devitrification.
A technology called nanowarming has emerged as one of the most promising solutions. The idea is to load the organ with iron-oxide nanoparticles along with the cryoprotectant, then apply a rapidly alternating magnetic field during rewarming. The nanoparticles generate heat from the inside out, throughout the tissue simultaneously, producing uniform warming rates that conventional methods cannot achieve. Experiments on rat hearts demonstrated that nanowarmed hearts avoided the cracking seen in conventionally rewarmed controls, retained tissue integrity comparable to fresh hearts, and even showed some residual electrical activity.17PubMed Central. Vitrification and Rewarming of Magnetic Nanoparticle-Loaded Rat Hearts
The technology has continued to scale. Recent work achieved uniform rewarming in volumes up to two liters of cryoprotectant solution, reaching warming rates of roughly 88 °C per minute using a newly developed 120-kilowatt radiofrequency coil.18PubMed Central. Physical vitrification and nanowarming at liter-scale CPA volumes: toward organ cryopreservation Two liters approaches the volume of a human kidney. Scaling further to the volume of a human liver, or an entire body, will require substantially larger and more powerful systems, but the physical principle has been validated.
Organ-Scale Cryopreservation Milestones
The most striking recent achievement in this field involves rat kidneys. In 2023, researchers demonstrated that rat kidneys could be vitrified, stored at cryogenic temperatures for up to 100 days, nanowarmed, and then transplanted into rats whose own kidneys had been removed. The transplanted kidneys restored full life-sustaining renal function.19PubMed Central. Vitrification and nanowarming enable long-term organ cryopreservation and life-sustaining kidney transplantation in a rat model This was the first time any organ had been frozen to glass, stored long-term, rewarmed, and shown to keep an animal alive as the sole functioning organ of its type. Earlier work had shown that individual rat kidneys could be nanowarmed from a vitrified state with promising signs of recovery, but had not taken the step of proving the organs could actually sustain life after transplantation.20PubMed Central. Vitrification and Nanowarming of Kidneys
Rat livers have also been vitrified and nanowarmed. While the results were less clean than with kidneys, with some elevation of liver enzymes and impaired clearance of a test dye, the nanowarmed livers were viable, maintained normal tissue architecture, and demonstrated hepatocyte-level function including bile production during reperfusion.21PubMed Central. Cryopreservation of Whole Rat Livers by Vitrification and Nanowarming These results are encouraging but also reveal the gulf between proof-of-concept in rat-sized organs and application to human-scale ones. A rat kidney weighs a few grams; a human kidney weighs about 150 grams. The challenges of perfusing cryoprotectant uniformly, cooling quickly enough to vitrify, and rewarming without thermal gradients all scale with organ size in unfavorable ways.
Preserving the Brain
For any version of cryosleep to be meaningful, the brain’s structure must survive intact, particularly the synaptic connections that encode memory and identity. A technique called aldehyde-stabilized cryopreservation (ASC) has shown that it is possible to achieve excellent ultrastructural preservation of entire mammalian brains. In experiments on rabbit and pig brains, researchers first chemically fixed the tissue, then gradually perfused it with increasing concentrations of ethylene glycol before vitrifying at −135 °C. Upon rewarming and cryoprotectant removal, electron microscopy showed uniformly excellent preservation across the whole brain, with neural processes easily traceable and synapses appearing crisp and intact in both species.22Cryobiology. Aldehyde-stabilized cryopreservation
The catch is that ASC uses chemical fixation as the first step, which kills the tissue. The technique is designed for research purposes like mapping neural wiring diagrams, not for reversible preservation of a living brain. It demonstrates that the physical structure encoding information in a brain can be captured and held in a vitrified state with remarkable fidelity, but it says nothing about whether a living brain could survive a similar process. Bridging that gap, vitrifying a brain without killing it first and recovering it with function intact, may be the single hardest problem in all of cryobiology.
Why Space Agencies Are Interested
The most practical near-term motivation for human torpor research comes not from medicine but from spaceflight. A crewed mission to Mars involves roughly six to nine months of transit each way. Keeping astronauts fed, hydrated, oxygenated, and psychologically stable for that long requires enormous quantities of consumables and a large habitable volume. If crew members could be placed in torpor for most of the journey, estimates suggest water and food needs could drop by up to 75%, radically reducing spacecraft mass.23PubMed Central. Hibernating astronauts-science or fiction? Beyond logistics, torpor could confer biological benefits: natural hibernators show resistance to radiation damage and muscle atrophy, two of the most serious health threats on long missions.
The European Space Agency has commissioned formal studies on torpor as a crew strategy for deep-space missions. These assessments concluded that inducing torpor in crew members could reduce payload requirements for oxygen, food, and water, though it would require sophisticated AI-assisted monitoring throughout the dormant period.24PubMed. European space agency’s hibernation (torpor) strategy for deep space missions: Linking biology to engineering The interest is serious enough that engineering studies have begun, but no human torpor protocol suitable for spaceflight exists yet. The research focus is on mild torpor, perhaps dropping core body temperature by a few degrees and reducing metabolic rate modestly, rather than the deep freeze of science fiction.
Legal and Ethical Questions That Already Exist
Even though reversible human cryosleep is not yet possible, the cryonics industry, which preserves the bodies or heads of recently deceased people in liquid nitrogen with the hope of future revival, has already created legal tangles. Under current law in England and Wales, and in most other jurisdictions, a person whose body has been cryopreserved is legally dead, since legal definitions of death follow medical criteria including irreversible loss of brainstem function.25PubMed Central. Cryopreservation and current legal problems: seeking and selling immortality This creates an uncomfortable set of questions about the rights and interests of people in cryonic storage: they are not patients receiving medical treatment, because they are dead, but the entire premise of cryonics is that they might not stay dead.
If cryosleep ever does become technically feasible, the legal framework will need to address scenarios with no real precedent. A person who enters cryosleep alive, with the expectation of waking up years later, is not dead by any current definition. But they are also not conscious, not able to manage their affairs, and potentially not waking up at all if the technology fails. Property law, contract enforcement, insurance, medical consent, and even family law would all need new frameworks. The analysis of current cryonics legal problems suggests that existing law is already ill-equipped to protect the interests of the dead and their next of kin in the context of cryopreservation. The challenges would only multiply if the person in storage were still legally alive.
Cold Shock Proteins and the Genetics of Cold Tolerance
One line of research looks at the molecular tools that cells already have for coping with cold. Humans possess a family of proteins known as cold shock proteins, the best characterized being Y-box binding protein-1 (YB-1). These are RNA- and DNA-binding proteins that regulate gene activity at multiple levels, influencing which genes get transcribed, how RNA is processed, and which proteins get made.26PubMed Central. Cold shock proteins: from cellular mechanisms to pathophysiology and disease In some contexts, cold shock proteins appear to have neuroprotective effects during cooling, helping cells survive conditions that would normally trigger cell death.
The question researchers are beginning to explore is whether these proteins could be deliberately upregulated, perhaps through gene therapy or pharmacological means, to make human tissue more tolerant of deep cooling. This is still firmly in the exploratory phase, with no approach close to clinical application. But the fact that human cells already carry some cold-response machinery suggests that extreme cold tolerance may not require wholesale genetic engineering from scratch. It might be a matter of amplifying systems that evolution built into our genomes but kept largely dormant because our lineage never needed to hibernate.